• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Longitudinal characterization of inflammatory plasma protein signatures in ECT response
 
  • Details
  • Full
Options
2026
Journal Article
Title

Longitudinal characterization of inflammatory plasma protein signatures in ECT response

Abstract
Background Electroconvulsive therapy (ECT) is an effective treatment for psychiatric disorders, but its molecular mechanisms are not yet fully elucidated. This study aimed to investigate longitudinal dynamics of inflammatory proteins during ECT and their association with clinical outcomes. Methods Protein expression was measured in 30 patients at multiple time points during the course of ECT using the Olink® inflammation panel. A longitudinal mixed-effects model was used to assess temporal changes in protein levels and their association with symptom severity. Patient-specific correlation analyses examined associations between individual symptom improvement trajectories and protein dynamics. Proteins associated with symptom improvement underwent pathway enrichment analysis to identify underlying signaling mechanisms. A linear model assessed associations between baseline protein expression and treatment response. Results Cystatin D showed significant longitudinal changes during ECT but was not associated with clinical response. Correlation analyses identified 18 immune-related proteins significantly linked to symptom improvement, with 17 showing negative correlations. Notably, IL-4 and IL-20 consistently emerged in both the correlation analysis and linear model, indicating a possible association with ECT-related molecular mechanisms. Pathway enrichment analysis revealed significant involvement of the JAK-STAT signaling pathway, aligning with existing evidence implicating this pathway in the pathophysiology of mood disorders and synaptic plasticity. Conclusion Symptom improvement during ECT is associated with reductions in specific inflammatory and neuroimmune markers, suggesting a potential link to the therapeutic mechanisms. These findings provide preliminary indications of immune involvement in ECT and emphasize the need for larger cohorts to validate results and further investigate immunomodulatory targets in psychiatric treatment.
Author(s)
Belschner, Hanna
Medizinische Fakultät Mannheim
Frank, Josef
Medizinische Fakultät Mannheim
Zillich, Eric
Medizinische Fakultät Mannheim
Sirignano, Lea
Medizinische Fakultät Mannheim
Kachel, K.
Universitätsmedizin Mainz
Engelmann, Jan
Universitätsmedizin Mainz
Schneider, Else
Universität Basel
Karl, Sebastian
Universität Heidelberg
Pedraz-Petrozzi, Bruno
German Center for Mental Health (DZPG)
Ziegler, Nicole
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Eckert, Anne
Universität Basel
Dukal, Helene
Medizinische Fakultät Mannheim
Brühl, Annette Beatrix
Universität Basel
Lieb, Klaus
Universitätsmedizin Mainz
Sartorius, Alexander
German Center for Mental Health (DZPG)
Zillich, Lea
Medizinische Fakultät Mannheim
Witt, Stephanie H.
Medizinische Fakultät Mannheim
Journal
Journal of affective disorders  
Open Access
File(s)
Download (2.62 MB)
Rights
CC BY 4.0: Creative Commons Attribution
DOI
10.1016/j.jad.2025.120494
10.24406/publica-6484
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Electroconvulsive therapy

  • Inflammation

  • Inflammatory proteins

  • Longitudinal

  • Major depressive disorder

  • Psychiatric treatment response

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024